404 related articles for article (PubMed ID: 17988927)
1. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
Merims D; Giladi N
Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
[TBL] [Abstract][Full Text] [Related]
2. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
Avanzi M; Uber E; Bonfà F
Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
[TBL] [Abstract][Full Text] [Related]
3. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
Fenu S; Wardas J; Morelli M
Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease].
Ardouin C; Chéreau I; Llorca PM; Lhommée E; Durif F; Pollak P; Krack P;
Rev Neurol (Paris); 2009 Nov; 165(11):845-56. PubMed ID: 19683776
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic dysregulation syndrome in Parkinson's disease.
Katzenschlager R
J Neurol Sci; 2011 Nov; 310(1-2):271-5. PubMed ID: 21868039
[TBL] [Abstract][Full Text] [Related]
6. Dopamine agonists and therapy compliance.
Grosset D
Neurol Sci; 2008 Dec; 29 Suppl 5():S375-6. PubMed ID: 19381766
[TBL] [Abstract][Full Text] [Related]
7. Drugs can trigger pathological gambling.
Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985369
[TBL] [Abstract][Full Text] [Related]
8. Pathological gambling and hypersexuality due to dopaminergic treatment in Parkinson' disease.
Martín Fernández F; Martín González T
Actas Esp Psiquiatr; 2009; 37(2):118-22. PubMed ID: 19401861
[TBL] [Abstract][Full Text] [Related]
9. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
[TBL] [Abstract][Full Text] [Related]
10. A case of hedonistic homeostatic dysregulation.
Kessel BL
Age Ageing; 2006 Sep; 35(5):540-1. PubMed ID: 16799178
[TBL] [Abstract][Full Text] [Related]
11. Medical hazards of the internet: gambling in Parkinson's disease.
Larner AJ
Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
[No Abstract] [Full Text] [Related]
12. Addiction as aberrant learning-evidence from Parkinson's disease.
Dagher A
Addiction; 2012 Feb; 107(2):248-50. PubMed ID: 22248132
[No Abstract] [Full Text] [Related]
13. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
[TBL] [Abstract][Full Text] [Related]
14. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Bayard S; Cochen De Cock V; Dauvillers Y
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
[TBL] [Abstract][Full Text] [Related]
16. [Impulse control disorders in Parkinson's disease].
Joutsa J; Kaasinen V
Duodecim; 2013; 129(22):2351-8. PubMed ID: 24397147
[TBL] [Abstract][Full Text] [Related]
17. Medication-related impulse control and repetitive behaviors in Parkinson disease.
Voon V; Fox SH
Arch Neurol; 2007 Aug; 64(8):1089-96. PubMed ID: 17698698
[TBL] [Abstract][Full Text] [Related]
18. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Montastruc JL; Schmitt L; Bagheri H
Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
[TBL] [Abstract][Full Text] [Related]
19. The nonmotor symptoms of Parkinson's disease--an overview.
Lim SY; Lang AE
Mov Disord; 2010; 25 Suppl 1():S123-30. PubMed ID: 20187234
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Parkinson's disease--where do we go from here?
Suchowersky O
Nat Clin Pract Neurol; 2006 Sep; 2(9):461. PubMed ID: 16932605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
